Literature DB >> 10875291

Echocardiographic parameters in reversible idiopathic dilated cardiomyopathy.

H Khanlou1, B Paltoo, W Forbes.   

Abstract

BACKGROUND: Reversible idiopathic dilated cardiomyopathy (IDCM) is a rare entity. It has been hypothesized that the degree of left ventricular end diastolic dilation is an important independent predictor of prognosis. We undertook a study to identify cases of reversible IDCM and to evaluate the echocardiographic findings in these patients.
METHODS: We identified 5 patients with IDCM who showed normalization of left ventricular function over a follow up period of 5 months. The findings were compared with those of 10 patients with IDCM who did not show improvement of left ventricular function. The mean (+/-SE) left atrial and left ventricular (LV) dimensions and ejection fraction at baseline and follow-up were compared in both groups.
RESULTS: There were no statistical differences between the mean (+/-SE) left atrium sizes in the cases and control group at baseline [4.52 (+/-0.24) cm v4.6 (+/-0.13) cm; P = 0.758]. Also, no differences were observed between mean (+/-SE) LV dimensions in diastole and systole in both groups at baseline [LV diastole, 6.72 (+/-0.35) cm versus 6.56 (+/-0.22) cm; P = 0.711; LV systole, 5.6 (+/-0.27) cm versus 5.59 (+/-0.29) cm; P = 0.712] as well as in mean (+/-SE) ejection fraction [24% (+/-3.96) versus 21.7% (+/-3.30); P = 0.623].
CONCLUSION: Based on initial echocardiographic parameters, chamber dimensions and baseline LV ejection fraction are not predictors of reversibility.

Entities:  

Mesh:

Year:  2000        PMID: 10875291     DOI: 10.1097/00000441-200006000-00004

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  1 in total

1.  Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.

Authors:  Jeonggeun Moon; Young-Guk Ko; Namsik Chung; Jong-Won Ha; Seok-Min Kang; Eui-Young Choi; Se-Joong Rim
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.